Mighty Capital

Mighty Capital is a San Francisco-based venture firm associated with Product School and a network of senior product leaders, with a thesis built around backing software companies whose advantage is rooted in product excellence and that can benefit from a community of practicing product executives. The firm’s footprint suggests Series A and Series B investments in B2B software, with selective consumer exposure. Healthcare exposure is incidental rather than central; healthcare and digital health appear when the company is fundamentally a software business with a strong product orientation rather than a clinical or regulated entity. AI focus is real and applied, with interest in AI-native productivity, vertical SaaS, and platform plays where machine learning is core to product differentiation. Stage is typically Series A through Series B, with checks plausibly in the USD 3M to USD 10M range as part of a syndicate, occasionally leading. This is the wrong door for therapeutics, devices, or care-delivery businesses where regulatory and clinical expertise is the unlock. It is a fit for healthcare software founders who have already validated product-market fit, are scaling revenue, and would benefit from access to a deep bench of product leaders for advisory and recruiting. Entry path is a warm introduction from a portfolio CEO or a Product School affiliate; founders should be ready with retention metrics, NPS, and a credible product-led growth story rather than a sector narrative.